Cash Equivalents - UBCare Co Ltd (KOSDAQ:032620) - Alpha Spread
U

UBCare Co Ltd
KOSDAQ:032620

Watchlist Manager
UBCare Co Ltd
KOSDAQ:032620
Watchlist
Price: 3 980 KRW 0.51% Market Closed
Market Cap: 202.6B KRW
Have any thoughts about
UBCare Co Ltd?
Write Note

UBCare Co Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

UBCare Co Ltd
Cash Equivalents Peer Comparison

Comparables:
D
315640
e
099750
C
311690
L
328130
J
322510

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
U
UBCare Co Ltd
KOSDAQ:032620
Cash Equivalents
â‚©26.5B
CAGR 3-Years
-24%
CAGR 5-Years
30%
CAGR 10-Years
14%
D
DeepNoid Inc
KOSDAQ:315640
Cash Equivalents
â‚©21.5B
CAGR 3-Years
30%
CAGR 5-Years
117%
CAGR 10-Years
N/A
e
ezCaretech Co Ltd
KOSDAQ:099750
Cash Equivalents
â‚©5.8B
CAGR 3-Years
-10%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
C
CJ Bioscience Inc
KOSDAQ:311690
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
L
Lunit Inc
KOSDAQ:328130
Cash Equivalents
â‚©31.6B
CAGR 3-Years
54%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
JLK Inc
KOSDAQ:322510
Cash Equivalents
â‚©6.1B
CAGR 3-Years
-22%
CAGR 5-Years
13%
CAGR 10-Years
N/A

See Also

What is UBCare Co Ltd's Cash Equivalents?
Cash Equivalents
26.5B KRW

Based on the financial report for Jun 30, 2024, UBCare Co Ltd's Cash Equivalents amounts to 26.5B KRW.

What is UBCare Co Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
14%

Over the last year, the Cash Equivalents growth was 16%. The average annual Cash Equivalents growth rates for UBCare Co Ltd have been -24% over the past three years , 30% over the past five years , and 14% over the past ten years .

Back to Top